JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area apoptosis survivin'

Search results for: 'research area apoptosis survivin'

A2604 Celastrol

Target: Proteasome

Summary: Antioxidant, anti-inflammatory and immunosuppressive agent

≥22.55 mg/mL
A4211 Lenalidomide (CC-5013)

Target: angiogenesis

Summary: Antineoplastic agent,inhibits angiogenesis

insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
A4212 Pomalidomide (CC-4047)

Summary: Immunomodulator,antumor/anti-angiogenic

insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
A4452 Mitomycin C

3 Citation

Summary: Inhibits DNA synthesis,antibiotic and antitumor agent

insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
A3007 ABT-263 (Navitoclax)

15 Citation

Target: Bcl-2|Bcl-w

Summary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w

≥48.73 mg/mL
A4390 Pemetrexed

1 Citation

Target: Thymidylate Synthase|DHFR|GARFT

Summary: TS, DHFR,GARFT and AICARFT inhibitor

insoluble in EtOH; ≥15.68 mg/mL
A8168 HA14-1

Target: Bcl-2

Summary: Bcl-2 inhibitor,potent and cell-permeable

insoluble in H2O; ≥20.45 mg/mL
A3750 Regorafenib hydrochloride

Target: Raf|VEGFR|PDGFR|c-Kit|c-RET

Summary: Tyrosine kinase inhibitor

≥25.95 mg/mL
A3023 P005091

1 Citation

Target: Ubiquitin-specific proteases

Summary: Ubiquitin-specific protease 7 (USP7) inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.4 mg/mL
A4116 Danusertib (PHA-739358)

2 Citation

Target: Aurora Kinases

Summary: Pan-aurora kinase inhibitor

≥23.75 mg/mL